JPRN-UMIN000017780已完成2 期
Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study - A feasibikity study of IMRT for locally advanced NSCLC
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active double cancer 2)History of severe infections or complications 3)HBs antigen positive 4)History of thoracic radiotherapy 5)Radiographically (chest CT image) confirmed interstitial pneumonitis or pulmonary fibrosis 6)Severe emphysema, chronic bronchitis, asthma 7)History of drug-induced pneumonia or severe drug allergies 8)Uncontrolled diabetes despite continuing treatment of insulin 9)Unstable angina, cardiac infarction within 6 months before enrollment 10)A fever of over 38 degrees 11)Continuous systemic administration of steroid or immunosuppressant 12)Pregnant women 13)Patients with severe mental illness 14)Unsuitable patients judged by the attending physician
研究者
相似试验
未知
不适用
Clinical study for Intensity Modulated RadiotherapyHepatic cancer, prostate cancer,brain, head and neck cancerJPRN-UMIN000000641Department of Radiology, Keio University5
招募中
不适用
Intensity modulated radiotherapy with IGRT for Post cricoid and upper esophageal cancer: Prospective observational studyCTRI/2017/11/010428Varian Medical Systems Inc
已完成
不适用
MRI for radiotherapy treatment planning of stage III NSCLC: an MRI optimization study in healthy volunteers and patients1003866610029107lung cancernon-small cell lung cancerNL-OMON44655niversitair Medisch Centrum Utrecht40
尚未招募
不适用
Ontwikkeling van een MRI-scanningsprotocol voor het afbeelden van stadium III niet-kleincellig longkanker.1. Healthy volunteers 2. Patients with stage III NSCLC MRINL-OMON27984niversity Medical Center Utrecht30
已完成
2 期
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By SurgeryCervical CancerEndometrial CancerNCT00331760Radiation Therapy Oncology Group106